Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Opportunistic Infections and Drug Rashes Oh My - Managing the Cutaneous Complications of Solid Organ Transplantation
Description
The presentation discusses managing cutaneous complications associated with solid organ transplantation, specifically focusing on opportunistic infections and drug rashes. Dr. Gallitano and Dr. Whitley address the history and evolution of transplant medicine, highlighting the immunosuppressive regimens used to prevent organ rejection and their resultant side effects. Key points include the heightened risk of opportunistic infections due to impaired immune response in transplant patients, with a prevalence of viral infections such as cytomegalovirus (CMV) and human papillomavirus (HPV). Various cutaneous manifestations from immunosuppressive therapies, like steroid acne and hair loss from tacrolimus, are discussed. The session emphasizes the importance of diagnosing and managing skin complications effectively, considering both classic and emerging therapies. Cutaneous viral infections, particularly those related to HPV and human polyomavirus, require close monitoring and the use of treatments ranging from topical therapies to systemic medications. Dr. Whitley highlights the significance of multidisciplinary care in managing these complex patients and illustrates practical management strategies. The talk concludes by emphasizing the continuing need for research and collaboration in the field of transplant dermatology, ensuring optimal patient outcomes.
View moreConclusions
- Immunosuppressive regimens in solid organ transplantation lead to a variety of cutaneous adverse events.
- Patients on immunosuppressive therapy are at increased risk for opportunistic infections, particularly skin infections.
- Common cutaneous complications in transplant recipients include steroid-induced acne, alopecia from calcineurin inhibitors, and pyoderma.
- Specific viral infections such as human papillomavirus and herpes viruses are more prevalent in transplant recipients due to immune suppression.
- Management of skin conditions in transplant recipients requires careful consideration of potential drug interactions and side effects.
- There is a notable risk of skin cancer in solid organ transplant patients, necessitating regular monitoring and preventative strategies.
- Newer agents like mTOR inhibitors may offer benefits in reducing certain skin cancer risks but also have their own associated skin side effects.
- Tailored approaches are necessary for managing inflammatory skin diseases, with a focus on individualized treatment plans for each patient.
- Portuguese AJ, Tykodi SS, Blosser CD, Gooley TA, Thompson JA, Hall ET. Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review. J Natl Compr Canc Netw. 2022 Apr;20(4):406-416.e11. doi: 10.6004/jnccn.2022.7009. PMID: 35390767.
- Page E, Kwun J, Oh B, Knechtle S. Lymphodepletional strategies in transplantation. Cold Spring Harb Perspect Med. 2013 Jul 1;3(7):a015511. doi: 10.1101/cshperspect.a015511. PMID: 23818516; PMCID: PMC3685881.
- Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R, Jaber S, Lanternier F, Luyt CE, Machado F, Mikulska M, Papazian L, Pène F, Poulakou G, Viscoli C, Wolff M, Zafrani L, Van Delden C. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients. Intensive Care Med. 2019 May;45(5):573-591. doi: 10.1007/s00134-019-05597-y. Epub 2019 Mar 25. PMID: 30911807; PMCID: PMC7079836.
- Naldi L, Venturuzzo A, Invernizzi P. Dermatological Complications After Solid Organ Transplantation. Clin Rev Allergy Immunol. 2018 Feb;54(1):185-212. doi: 10.1007/s12016-017-8657-9. PMID: 29177692.
- Chin-Hong PV, Reid GE; AST Infectious Diseases Community of Practice. Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 Sep;33(9):e13590. doi: 10.1111/ctr.13590. Epub 2019 Jun 20. PMID: 31077438.
- Russo M, Wheless W, Vrochides D. Management of long-term complications from immunosuppression. Liver Transplantation. 2024; 30(6): 647-658. doi: 10.1097/LVT.0000000000000341.